Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-09-06 00:00:00 ET · period of report 2023-07-15 · accession 0001415889-23-013048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-06 | 2023-07-15 | KNSA | Megna Michael R | CAO | A - Grant | $12.35 | +581 | 13.6K | +4% | +$7,175 |
| DM | 2023-09-06 | 2023-09-01+ | KNSA | Megna Michael R | CAO | M - OptEx | — | +4,707 | 17.1K | +38% | — |
| DM | 2023-09-06 | 2023-09-01+ | KNSA | Megna Michael R | CAO | F - Tax | $17.76 | -1,383 | 16.3K | -8% | -$24.6K |
| DM | 2023-09-06 | 2023-09-01+ | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -4,707 | 11.8K | -29% | $0 |
| DM | 2023-09-06 | 2023-09-01 | KNSA | Megna Michael R | CAO | A - Grant | $0.00 | +30.7K | 20.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-07-15 | A | A | 581 | $12.35 | 13,558 | D | — | — | |
| 2 | Common | Class A Common Share | 2023-09-01 | M | A | 3,933 | — | 17,491 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 3 | Common | Class A Common Share | 2023-09-02 | F | D | 228 | $17.76 | 16,882 | D | — | — | |
| 4 | Common | Class A Common Share | 2023-09-02 | M | A | 774 | — | 17,110 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 5 | Common | Class A Common Share | 2023-09-01 | F | D | 1,155 | $17.76 | 16,336 | D | — | — | |
| 6 | Derivative | Restricted Share Unit | 2023-09-02 | M | D | 774 | $0.00 | 1,549 | D | — · — to — | 774 Class A Common Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F6) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 2, 2021. |
| 7 | Derivative | Restricted Share Unit | 2023-09-01 | A | A | 10,230 | $0.00 | 10,230 | D | — · — to — | 10,230 Class A Common Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F4) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2023. |
| 8 | Derivative | Restricted Share Unit | 2023-09-01 | M | D | 3,933 | $0.00 | 11,797 | D | — · — to — | 3,933 Class A Common Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F3) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2022. |
| 9 | Derivative | Share Option | 2023-09-01 | A | A | 20,459 | $0.00 | 20,459 | D | $17.76 · — to 2033-08-31 | 20,459 Class A Common Share | (F5) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023. |